SCHEMBL3661750

SCHEMBL3661750

CCOC(=O)c1nc(Br)c2c(-c3ccccc3)noc2c1O.CCOC(=O)c1ncc2c(-c3ccccc3)noc2c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
ATM Q13315 1/20 0.41
GABRA5 P31644 1/20 0.40
CACNA1F O60840 1/20 0.39
CACNA1D Q01668 1/20 0.39
CACNA1S Q13698 1/20 0.39
CACNA1C Q13936 1/20 0.39
TARBP2 Q15633 1/20 0.39
ADORA3 P0DMS8 3/20 0.38
HPGD P15428 2/20 0.37
KMT2A Q03164 2/20 0.37
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2774203 0.91 TARBP2 (0.45) ALDH1A1MAPTSMN1; SMN2MAPK1LMNA
SCHEMBL2776420 0.89 ALDH1A1 (0.46) ALDH1A1MAPTSMN1; SMN2MAPK1LMNA
SCHEMBL2777401 0.83 TARBP2 (0.45) ALDH1A1MAPTSMN1; SMN2MAPK1LMNA
SCHEMBL2777413 0.81 ADORA3 (0.48) ALDH1A1MAPTSMN1; SMN2MAPK1LMNA
SCHEMBL2775027 0.80 CDC7 (0.44) ALDH1A1MAPK1GABRA5HPGDHSD17B10
SCHEMBL2776301 0.80 TARBP2 (0.46) ALDH1A1MAPTSMN1; SMN2MAPK1LMNA
SCHEMBL2776306 0.79 ALDH1A1 (0.43) ALDH1A1MAPTSMN1; SMN2MAPK1LMNA
SCHEMBL2776184 0.78 TARBP2 (0.48) ALDH1A1MAPTGABRA5TARBP2KMT2A
SCHEMBL2774268 0.78 ALDH1A1 (0.47) ALDH1A1MAPTSMN1; SMN2MAPK1LMNA
SCHEMBL2778440 0.77 TARBP2 (0.43) ALDH1A1MAPTSMN1; SMN2MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227475-A1 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS Fibrogen, Inc. (US) 2010-09-15 EP disclosed
WO-2009073669-A1 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS FIBROGEN, INC. (US) 2009-06-11 WO disclosed